Mental Retardation and Developmental Disabilities Research Centers 2006

The summary for the Mental Retardation and Developmental Disabilities Research Centers 2006 grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Mental Retardation and Developmental Disabilities Research Centers 2006: - The National Institute of Child Health and Human Development (NICHD) invites applications for Center Core Grants designed to advance the diagnosis, prevention, treatment, and amelioration of mental retardation and developmental disabilities (MRDD). This Request for Applications (RFA) seeks applications from institutions that meet the qualifications for a program of MRDD research as specified at: http://www.nichd.nih.gov/funding/dsr_p30_guide.htm. The grants fund core resources to support interdisciplinary research and research training. Funds for the research projects using these core facilities come from independent sources including Federal, State, and private organizations. - The total amount to be awarded is approximately $ 4.7 million in FY2006. - The NICHD anticipates making up to four awards. - This RFA will use the NIH Center Core Grant (P30) mechanism. - Eligible organizations include domestic non-profit and for-profit organizations; public or private institutions, such as universities, colleges, hospitals, and laboratories; units of State or local government; and eligible agencies of the Federal government. Foreign institutions are not eligible for these grants. - Eligible principal investigators include scientists or science administrators who can provide effective scientific and administrative leadership. She/he should be able to integrate and synthesize the proposed research and, thereby, serve as an example to other investigators. - An institution may submit one application in response to this RFA. - The PHS 398 application kit is available at http://grants.nih.gov/grants/funding/phs398/phs398.html in an interactive format. Telecommunications for the hearing impaired is available at: TTY 301-451-0088.

Federal Grant Title:	Mental Retardation and Developmental Disabilities Research Centers 2006
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health Income Security and Social Services
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-HD-05-030
Type of Funding:	Grant
CFDA Numbers:	93.865
CFDA Descriptions:	National Institute of Child Health and Human Development Extramural Research
Current Application Deadline:	No deadline provided
Original Application Deadline:	Dec 21, 2005
Posted Date:	Sep 29, 2005
Creation Date:	Sep 29, 2005
Archive Date:	Jan 20, 2006
Total Program Funding:	$4,700,000
Maximum Federal Grant Award:	$750,000
Minimum Federal Grant Award:
Expected Number of Awards:	4
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Public and State controlled institutions of higher education Private institutions of higher education State governments County governments City or township governments Special district governments Independent school districts Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Eligible agencies of the Federal Government are eligible to apply. Foreign institutions are not eligible to apply. For the purpose of this RFA, the NICHD will support no more than one MRDDRC grant (P30) per institution. To be eligible for an award, the proposed Center must provide core support for a minimum of 10 projects funded from non-university sources. Additional eligibility criteria for the P30 are listed in the NICHD P30 CENTER CORE GRANT GUIDELINES at: http://www.nichd.nih.gov/funding/dsr_p30_guide.htm.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
Similar Government Grants: • Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allo...; • National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50 C...; • Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescen...; • Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed); • Biological Testing Facility (X01 Clinical Trial Not Allowed); • Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Precli...; • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...; • Reproductive Genetics and Epigenetics
More Grants from the National Institutes of Health: • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...; • NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...; • Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...